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ABSTRACT Recent advances in unbiased pathogen discovery have implicated astro-
viruses as pathogens of the central nervous system (CNS) of mammals, including hu-
mans. However, the capacity of astroviruses to be cultured in CNS-derived cells in
vitro has not been reported to date. Both astrovirus VA1/HMO-C (VA1; mamastrovi-
rus 9) and classic human astrovirus 4 (HAstV4; mamastrovirus 1) have been previ-
ously detected from cases of human encephalitis. We tested the ability of primary
human neurons, primary human astrocytes, and other immortalized human nervous
system cell lines (SK-N-SH, U87 MG, and SW-1088) to support infection and replica-
tion of these two astrovirus genotypes. Primary astrocytes and SK-N-SH cells sup-
ported the full viral life cycle of VA1 with a 100-fold increase in viral RNA levels
during a multistep growth curve, detection of viral capsid, and a 100-fold increase
in viral titer. Primary astrocytes were permissive with respect to HAstV4 infection
and replication but did not yield infectious virus, suggesting abortive infection. Simi-
larly, abortive infection of VA1 was observed in SW-1088 and U87 MG cells. Elevated
expression of the chemokine CXCL10 was detected in VA1-infected primary astro-
cytes and SK-N-SH cells, suggesting that VA1 infection can induce a proinflammatory
host response. These findings establish an in vitro cell culture model that is essential
for investigation of the basic biology of astroviruses and their neuropathogenic po-
tential.
IMPORTANCE Encephalitis remains a diagnostic conundrum in humans as over 50%
of cases are managed without the identification of an etiology. Astroviruses have
been detected from the central nervous system of mammals in association with dis-
ease, suggesting that this family of RNA viruses could be responsible for cases of
some neurological diseases that are currently without an ascribed etiology. However,
there are significant barriers to understanding astrovirus infection as the capacity of
these viruses to replicate in nervous system cells in vitro has not been determined.
We describe primary and immortalized cultured cells of the nervous system that
support infection by astroviruses. These results further corroborate the role of astro-
viruses in causing neurological diseases and will serve as an essential model to inter-
rogate the neuropathogenesis of astrovirus infection.
KEYWORDS astrovirus, astrovirus VA1, cell culture, encephalitis, virology
Inflammation of the brain, known as encephalitis, is a significant diagnostic conun-drum for clinicians and researchers. While diverse numbers of viruses, bacteria, fungi,
and parasites have been implicated in causing encephalitis, 30% to 63% of cases are
without an identified etiology despite comprehensive testing for many of these known
etiological agents (1–4). Encephalitis results in significant morbidity and mortality, as
death occurs in 5% of patients, and in those that survive, 75% of children and
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50% of adults develop long-term neurological sequelae (5–8). The recent application
of unbiased next-generation sequencing to the challenge of encephalitis has identified
multiple astrovirus species from cases of neurological disease in multiple mammalian
species, including several cases in humans (9–16). Astroviruses comprise a family of
single-stranded, positive-sense RNA viruses originally identified from stool samples of
children with gastroenteritis (17, 18), with some viral particles having a distinct star-like
morphological appearance as revealed by electron microscopy (19). Since 1975, mul-
tiple astrovirus genotypes have been identified from vertebrate samples, and the
International Committee on Taxonomy of Viruses currently recognizes 22 astrovirus
species (20). There are four species of astroviruses that have been frequently
identified from human samples, including mamastrovirus 1 (representative strain
human astrovirus 1), mamastrovirus 6 (representative strain MLB1), mamastrovirus
8 (representative strain VA2/HMO-A), and mamastrovirus 9 (representative strain
VA1/HMO-C [VA1]) (20, 21).
While astroviruses are traditionally considered to be primary pathogens of the
gastrointestinal tract, to date, nine cases of central nervous system (CNS) disease in
humans have been attributed to astroviruses, including five cases of astrovirus VA1
encephalitis, two cases of astrovirus MLB2 meningoencephalitis, and single cases
identified for astrovirus MLB1 and classic human astrovirus 4 (HAstV4) (9–16). Further-
more, astroviruses have been implicated in causing CNS infection in other mammals.
Bovine astroviruses were detected in 34% of cases of unexplained encephalitis in cattle
(22), and a novel mink astrovirus is associated with shaking mink syndrome, a neuro-
logical disease of minks characterized by tremors, ataxia, and seizures (23, 24). Astro-
viruses have also been detected in cases of neurological diseases in pigs and sheep
(25–29). Because astroviruses were identified to have a neurotropism only recently and
because of the lack of clinical diagnostic testing for astroviruses, the true burden of
astrovirus-associated neurological diseases is unknown for many mammals. Given that
a majority of cases of human encephalitis are without an identified etiology and the
high frequency at which bovine astroviruses were detected in bovine encephalitis cases
previously without an etiology, there is a distinct possibility that astroviruses could be
responsible for cases of some neurological diseases in humans (1–4, 22).
The potential cellular tropisms of VA1 in the human CNS have been described
previously in three cases of VA1-associated encephalitis (9–11). Astrocytes have been
implicated in supporting replication in one study as VA1 capsid colocalizes with cells
expressing glial fibrillary acidic protein (GFAP), a specific protein marker of astrocytes
(9). In addition, VA1 capsid or RNA has also been identified in cells having a morpho-
logical appearance most similar to neurons although the neuronal lineage of VA1-
positive cells was not confirmed by colocalization with any neuron-specific markers in
any of the studies (9–11). In astrovirus-associated CNS diseases in other mammals,
bovine and porcine astrovirus RNA or proteins have been predominantly detected in
neurons (22, 28–30), while there has been only rare detection of bovine astroviruses in
microglia cells (22, 30).
Although astroviruses have been propagated in multiple cell culture lines derived
from non-CNS cell lineages, there are no published reports of astrovirus infection and
replication in CNS cells. None of the astrovirus genotypes detected from nonhuman
cases of CNS diseases have been propagated in cell culture. Among the astrovirus
genotypes detected from cases of human CNS disease, growth in cell culture has been
reported only for HAstV4 and VA1 (31, 32) but not in any CNS-derived cell. Therefore,
we sought to develop the first CNS cell culture model of astrovirus infection using two
astrovirus genotypes, VA1 and HAstV4, that have been detected in human brain tissues
in cases of encephalitis (9–13, 16). On the basis of the reported localization of VA1 to
astrocytes and neurons in these cases, we evaluated the capacity of VA1 and HAstV4 to
productively infect primary cells from these lineages and from related immortalized cell
lines.
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RESULTS
Generation and sequencing of VA1 stock for infections. We developed a high-
titer VA1 viral stock by two rounds of passage in Caco-2 cells from our previously
described virus stock (31). The final VA1 stock (C-P7) had a concentration of 3.16 107
50% tissue culture infective dose (TCID50) units/ml. All subsequent experiments used
this stock. Whole-genome sequencing identified one additional genetic variant at
nucleotide position A5470U compared to the previous stock virus (KY933670.1). This
genetic variant occurs in ORF2, encoding the capsid, and resulted in a Y-to-F substi-
tution. We confirmed replication of this VA1 stock in Caco-2 cells (Fig. 1a; see also
Fig. 2), which were previously described to support replication of astroviruses (31, 32).
Infection of primary astrocytes and neurons by VA1 and HAstV4. In the previ-
ously described cases of VA1 encephalitis, VA1 had been detected in astrocytes and
possibly in neurons of the cerebral cortex (9–11). We therefore tested the ability of
primary cultures of these human cell types to support replication of VA1 and HAstV4.
In primary astrocytes, an approximate 100-fold increase in the level of VA1 genomic
RNA (gRNA) in the cellular fraction was detected 36 h after inoculation, with a 1,000-fold
increase in the gRNA level in the supernatant fraction seen 96 h postinoculation
(Fig. 1a). In addition, the infectious viral titer of VA1 increased in astrocytes over time,
with a significant increase of 100-fold (P 0.0083) in the viral titer at 96 h (Fig. 2). No
cytopathic effect was observed in VA1-infected astrocytes.
We next determined if genetic variants of VA1 would be selected for by serial
passaging the virus twice in primary astrocytes. The VA1 gRNA copy numbers in the cell
lysates were similar for the two passages; passage 1 (A-P1) gave 654,450 RNA copies/ml
and passage 2 (A-P2) gave 451,750 RNA copies/ml. We sequenced the VA1 genome
from A-P2 and did not identify any new genetic variants relative to the starting
inoculum (C-P7 stock).
We also observed an increase of over 10-fold in the levels of HAstV4 RNA in primary
astrocytes in both the cellular and supernatant fractions (Fig. 1b). While we could detect
an increase in the infectious titer of HAstV4 in Caco-2 cells over time, we did not detect
an increase at 48 or 96 h postinoculation in primary astrocytes (for both time points,
P0.47) or evidence of cytopathic effect (Fig. 2). These findings suggest that HAstV4
RNA replication, but not the complete life cycle, occurs in primary astrocytes.
Inoculation of primary cultures of pooled neuronal subtypes did not result in a rise
in the level of gRNA for VA1 or HAstV4 or in any detectable cytopathic effect (Fig. 1a
and b). We confirmed the capacity of the primary neurons to support viral replication
as the Venezuelan equine encephalitis virus (VEEV) strain TC-83 had a significant
increase in viral RNA over time with associated cytopathic effect (see Fig. S2 in the
supplemental material). This would suggest that primary neurons are nonpermissive
with respect to astrovirus infection under these experimental conditions.
Infection of immortalized cells representing the CNS. Next, we assessed the
capacity of immortalized cell lines to support replication of VA1 and HAstV4. Since
primary astrocytes supported the full VA1 life cycle, we selected two immortalized cell
lines from the glial lineage, namely, SW-1088 cells (derived from an astrocytoma) and
U87 MG cells (derived from glioblastoma), to assess their permissiveness with respect
to infection by the use of multistep growth curves. Both cell lines have been previously
described to be permissive to infection by other neurotropic viruses, including Zika
virus, Semliki Forest virus, and minute virus of mice (33–36). We also evaluated the
capacity of SK-N-SH cells (derived from neuroblastoma), a common immortalized cell
line used to study CNS viral infections (37–39). All three cell lines had increases in VA1
gRNA levels (Fig. 1a). For SK-N-SH cells, an approximate 80-fold increase in the level of
VA1 gRNA in the cellular fraction was detected at 36 h postinoculation and was
associated with an increase in the supernatant fraction starting 48 h after inoculation
(Fig. 1a). Overall, the kinetics of the multistep growth curves for VA1 for SK-N-SH cells
was similar to those for primary astrocytes. For SW-1088 and U87 MG cells, VA1 gRNA
levels did not start to increase until 48 h postinoculation in the cellular fraction, with a
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FIG 1 Multistep growth curves of (a) VA1 and (b) HAstV4 gRNA of primary astrocytes, primary neurons, and immortalized cell lines, including
SK-N-SH, SW-1088, U87 MG, and Caco-2 cells. Each data point is normalized to the gRNA copy number present at 1 h postinoculation for each
cell line. Geometric means are plotted with error bars representing 1 geometric standard deviation. The horizontal dotted line represents the
relative gRNA copy number at 1 h postinoculation.
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further increase detectable at 96 h postinoculation (Fig. 1a). No increase in the level of
VA1 gRNA in the supernatant fraction was observed at any time point for these two cell
lines (Fig. 1a). A significant (P 0.005) increase in the VA1 infectious titer was observed
at 96 h in SK-N-SH cells but not in SW-1088 or U87 MG cells (Fig. 2). These results
demonstrate that the full VA1 life cycle can be completed in SK-N-SH cells whereas
nonproductive or abortive infection occurs in SW-1088 and U87 MG cells. As for HAstV4,
we did not detect an increase in HAstV4 RNA levels in SW-1088 or U87 MG cells, while
there was a small (5-fold) increase in the level of HAstV4 RNA in the cellular fraction of
SK-N-SH cells (Fig. 1b). We also confirmed the capacity of SW-1088 and U87 MG cells to
support viral replication, as infection with the VEEV TC-83 strain resulted in significant
increases in the levels of viral RNA and of cytopathic effect in both cell lines (Fig. S2).
We next sought to characterize VA1 infection using a high multiplicity of infection
(MOI) of 3 in the CNS cell lines, having previously demonstrated their permissiveness
with respect to VA1 gRNA replication. The expected increases in VA1 gRNA levels were
observed in Caco-2, primary astrocyte, SK-N-SH, SW-1088, and U87 MG cells (Fig. 3). We
again observed an increase in the levels of VA1 gRNA in the supernatant of primary
astrocyte, SK-N-SH, and Caco-2 cells at 48 h postinoculation.
To evaluate viral infection at the single-cell level, we established a VA1 immunoflu-
orescence assay (IFA) using a polyclonal antibody (Ab) to detect the VA1 capsid in cells
infected at an MOI of 3. In Caco-2 cells, we detected strong punctate staining that was
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not observed in either mock-inoculated cells (Fig. 4) or VA1-inoculated cells stained
with preimmune sera (data not shown). Similar punctate staining was also observed in
primary astrocytes and SK-N-SH cells 48 h postinoculation (Fig. 4). However, we did not
identify any VA1 capsid-positive SW-1088 or U87 MG cells (Fig. 4). Overall, as observed
by microscopy, 0.37% of primary astrocytes, 0.81% of SK-N-SH, and 1.1% of Caco-2 cells
had the characteristic punctate staining in the immunofluorescence assay.
Characterization of abortive infection of VA1. During active replication, astrovi-
ruses produce a subgenomic RNA (sgRNA) strand encoding ORF2 which is translated to
express the capsid protein (21, 31). Because we could not detect VA1 capsid in SW-1088
or U87 MG cells, we examined whether there was a defect in production of sgRNA in
these cell types. We quantified the number of sgRNA copies by reverse transcription-
quantitative PCR (qRT-PCR) and analyzed the copy number by the use of two-way
analysis of variance (ANOVA) with cell type and times postinoculation (24, 36, and 48 h)
as factors. There was no significant effect of the interaction between the factors [F(6,
60)  0.6, P 0.72], but cell type had a significant effect [F(3,60)  53.1, P  0.0001].
In post hoc analysis of each time point (24, 36, and 48 h), we detected significantly
decreased quantities of sgRNA in SW-1088 or U87 MG cells compared to primary
astrocytes or SK-N-SH cells (P0.0013 for all post hoc comparisons) (Fig. 5). Thus, the
IFA and sgRNA results are consistent with a model where U87 and SW-1088 have
limited ability to express VA1 capsid.
Cytokine expression by nervous system cells inoculated with VA1. Clinically,
encephalitis is characterized by infiltrates of inflammatory cells. Since VA1 did not
induce cell lysis, we reasoned that infection by VA1 might induce expression of
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FIG 4 Detection of VA1 capsid in infected cells by immunofluorescence. Cells were incubated with
polyclonal antibody to the capsid and labeled by staining with a secondary antibody conjugated with a
green fluorescent dye. Merged fluorescence images are shown with counterstaining of nuclei (performed
with DAPI). White scale bars represent 10 m.
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proinflammatory cytokines that would result in migration of inflammatory cells. To test
this in vitro, we used a multiplex enzyme-linked immunosorbent assay (ELISA) to
quantify the levels of the following 10 cytokines in the supernatant: interferon alpha 2
(IFN-2), interferon gamma (IFN-), tumor necrosis factor alpha (TNF-), interleukin-1
(IL-1), IL-1, monocyte chemoattractant protein 1 (MCP-1), CXCL10/IP-10, IL-6, IL-8,
and vascular endothelial growth factor (VEGF). We identified 5-fold to 60-fold increases
in CXCL10 levels in the supernatant of VA1-infected primary astrocytes or SK-N-SH cells
(Fig. 6). We also detected small changes in IL-8 from infected primary astrocytes and
IL-6 in infected primary astrocytes, SK-N-SH, and SW-1088 cells (Fig. 6). There was no
change in the level of expression of MCP-1 or IFN-2 in infected cells (Fig. 6). VEGF and
IFN- also did not have altered expression upon infection, and many samples did not
have detectable amounts of IFN-, TNF-, IL-1, or IL-1 (data not shown). We further
corroborated the results of the CXCL10 and MCP-1 ELISA by qRT-PCR of host mRNA.
There were significant increases in the numbers of CXCL10 transcripts in primary
astrocytes and SK-N-SH cells, but MCP-1 expression did not significantly change upon
infection in multiple cell lines except 48 h postinoculation in SK-N-SH cells (Fig. 7).
DISCUSSION
The recent detection of astroviruses from human and other mammalian brain tissue
has identified this family of viruses as newly recognized neuropathogens. However, to
date, no astrovirus has been cultivated in any CNS cell line. Here, we describe the ability
of both primary astrocytes and SK-N-SH cells to support the complete life cycle of VA1,
as evidenced by increasing levels of viral gRNA and sgRNA over time, detection of
intracellular viral capsid, and increasing infectious viral titers over time. The develop-
ment of a CNS cell culture system is integral to understanding the neuropathogenesis
of VA1 and other mammalian astroviruses that have been associated with neurological
diseases. Furthermore, we identified additional cell types that appear to be permissive
with respect to both VA1 and HAstV4 infection and replication; however, these cells are
unable to complete the viral life cycle, as no increase in the infectious titer could be
detected. Nonetheless, these cell lines can also make valuable contributions to under-
standing of viral pathogenesis, as for some virus-mediated CNS diseases, such as those
involving rabies virus or La Crosse virus, abortive infection is an important component
of disease pathogenesis (40–42).
The isolate of VA1 used in this study was derived from a stool sample from the
original outbreak of VA1-associated gastroenteritis (43). There are 3.4% to 4.6% nucle-
otide and 1 to 3.2% amino acid polymorphisms between the four published genome
sequences of VA1 from encephalitis cases and the reference stool case (9–12, 43). From
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the molecular epidemiologic data alone, it was not clear whether all VA1 viruses have
neurotropic potential or whether specific viral variants or adaptations are required for
neurotropism. Our data suggest that genotypes of VA1 found in human stool have the
ability to replicate in CNS cells in vitro. Humans are frequently exposed to VA1, as
seroprevalence is 65% in adulthood, but it is unclear what subset of exposures leads to
encephalitis (44). All five VA1 encephalitis cases occurred in immunocompromised
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patients who either had X-linked agammaglobulinemia or had recently received a
hematopoietic stem cell transplant, suggesting that host immunity may play an im-
portant role in further modulating the risk of developing encephalitis. This risk could be
further potentiated by the different genotypes of VA1, as the genotypes from the cases
of VA1-associated encephalitis could contain genetic variants that confer even greater
CNS pathogenicity. We assessed whether there was high evolutionary pressure on the
stool-derived VA1 genome with two serial passages in primary astrocytes, but we did
not detect any new genetic variants in the viral genome. Further long-term passaging
experiments might identify genetic variants that do confer greater replicative capacity
in astrocytes. The effect on replication of the currently known genetic variants between
the stool-derived and brain-derived VA1 genotypes could be tested in the future with
development of a reverse genetics system.
In one of the VA1-associated encephalitis cases, VA1 capsid was localized to
astrocytes by immunohistochemistry performed with costaining for GFAP (9). Consis-
tent with this finding, we demonstrated that primary astrocytes are fully permissive for
VA1 infection. In three of the cases of VA1-associated encephalitis, VA1 RNA or capsid
was detected in cells with a morphology most consistent with neurons. However, we
did not detect any increase in astrovirus gRNA levels in primary neurons. It is formally
possible that the cells described in the published cases of encephalitis were not
neurons as neuron-specific markers were not used to colocalize the virus. Alternatively,
the primary neuronal culture system that we used may not fully mimic the in vivomilieu
of the human brain that is required for astrovirus infection. Furthermore, there may be
specific neurons derived from specific lineages or locations within the brain that are
permissive with respect to astrovirus infection that are not included in the pooled
neuronal cultures. We did identify completion of the full life cycle in SK-N-SH cells, an
immortalized neuroblastoma cell line commonly used to model CNS viral infections.
This cell line could provide future insights into particular CNS lineages or states of
differentiation that support VA1 infection, as SK-N-SH cells can be induced to differ-
entiate by retinoic acid (45).
When SW-1088 and U87 MG cells were inoculated with VA1, an increase in the level
of VA1 gRNA was observed, but this was associated with delayed production of sgRNA
and lack of detection of VA1 capsid or infectious viral particles. Thus, these cells appear
to be permissive with respect to virus entry and replication but are incapable of
completing the entire viral life cycle. It is possible that these cells lack expression of an
essential proviral gene or, alternatively, that they might express an inhibitory factor that
prevents completion of the full VA1 life cycle. U87 MG and SW-1088 cells have elevated
production of IL-6 and IL-8 in comparison to cell lines that support the full viral life
cycle, as these cytokines contribute to their oncological pathogenicity (46, 47). IL-6 can
potentiate the antiviral effect of interferon alpha, and exogenous IL-8 can inhibit HIV
replication, raising the possibility that these cytokines could confer additional antiviral
effects that contribute to abortive VA1 infection (48, 49).
CXCL10 expression was significantly increased upon infection of VA1 in primary
astrocytes and SK-N-SH cells. CXCL10 is an important chemoattractant induced by
many other viruses upon infection, resulting in recruitment of immune cells (50). In
addition, CXCL10 has been noted to induce neuronal apoptosis, contributing to viral
pathogenicity upon infection, including infection by West Nile virus (51–53). Infiltrates
of lymphocytes and loss of neurons were identified in the histological examinations of
the cases of VA1 encephalitis (9–11), and CXCL10 could be an important mediator of
this observed inflammatory response to infection. Further development of an in vivo
model of VA1 infection would better characterize the role of this cytokine upon VA1
infection.
Abortive infection with RNA replication has not been previously reported for any
classic human astrovirus in a CNS cell line. In the published case report of HAstV4
encephalitis, brain tissue was positive for viral RNA by PCR but viral capsid was not
detectable by immunohistochemistry, consistent with our model of abortive infection
(16). These findings would suggest that there are differences between the host-virus
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interactions of HAstV4 and astrocytes and those of VA1 and astrocytes. Our in vitro
observations suggest that VA1 has a greater capacity to cause CNS infections. We
previously described one key distinction, as, in contrast to the classic human astrovi-
ruses, VA1 does not require trypsin for propagation in cell culture (54). One possibility
is that for HAstV4, nervous system cells may require trypsinization conditions different
from those that enable productive infection of Caco-2 cells. It is also possible that
astrocytes are inherently capable of supporting only abortive infection of HAstV4.
Alternatively, our HAstV4 genotype may not be well adapted for infection of the CNS
as it was originally isolated from stool. Abortive infection may still be relevant to the
host, as an inflammatory response could be induced in the absence of the completion
of the full viral life cycle. While we did detect small increases in the levels of CXCL10 and
IL-6 with abortive infection of VA1 in SW-1088 cells, it is unclear whether these
increases are biologically significant, and further characterization may reveal host
responses that are significantly induced by abortive infection.
In summary, we have developed the first cell culture system of astrovirus infection
in nervous system cells. This is another important step in demonstrating the pathoge-
nicity of astroviruses in causing neurological diseases, and we can now begin to explore
the essential viral and host factors that contribute to CNS disease. Growth of a virus in
pure culture fulfills one of Koch’s postulates. If an in vivo model of CNS infection by
astrovirus VA1 could be developed, this would be the final step in fulfilling Koch’s
postulates and demonstrate that astrovirus VA1 is a bona fide pathogen of the CNS.
MATERIALS AND METHODS
Cell culture. All cells were maintained at 37°C with 5% CO2. Caco-2, SW-1088 (HTB-12; ATCC),
SK-N-SH (HTB-11; ATCC), and U87 MG cells were maintained in Dulbecco’s modified Eagle media (DMEM)
with L-glutamine (Gibco) supplemented with 10% fetal bovine serum (FBS; Gibco) and 1% of 10,000
units/ml of penicillin/streptomycin (Gibco).
Primary human astrocytes from the cerebral cortex were commercially purchased and maintained in
astrocyte media with 2% FBS, astrocyte growth supplement, and penicillin/streptomycin (Sciencell). Cells
were seeded on poly-L-lysine (Sigma)-treated tissue culture plasticware at 2 g/cm2. For all experiments,
the passage number for astrocytes was less than or equal to two. Primary neurons pooled from several
brain regions were also commercially purchased and maintained in neuronal media supplemented with
neuronal growth supplement and penicillin/streptomycin (Sciencell). Neurons were maintained on
poly-L-lysine-coated plasticware (2 g/cm2) and allowed to incubate 10 to 14 days for neurite maturation
prior to any experimentation.
Virus infection protocols. VA1 infections were performed as previously described (31, 55), and the
same conditions were used for VEEV TC83 infections. For infections performed with HAstV4, an aliquot
of the virus was activated with 100 g/ml of trypsin for 30 min (56). VA1 or VEEV aliquots were not
pretreated with trypsin. VA1, HAstV4, or VEEV aliquots were diluted in DMEM or in astrocyte/neuronal
media without FBS. Cells were washed once with serum-free media (SFM), incubated with the virus
mixture for 1 h, and washed once with SFM. For cells incubated with VA1 or VEEV, growth media with
FBS was added to the cells. For HAstV4, SFM supplemented with 3.3 g/ml of trypsin was added to the
cells except for SK-N-SH and primary neurons. In pilot studies, we identified death of SK-N-SH cells
maintained in serum-free media. Significant detachment also occurred in SK-N-SH cells and primary
neurons treated with trypsin. Therefore, HAstV4-inoculated SK-N-SH cells were maintained in media
containing FBS without trypsin, and no trypsin was added to the growth media of HAstV4-inoculated
neurons.
Generation of viral stocks. Using a previously published VA1 stock (C-P5) (31), Caco-2 cells grown
in T175 flasks were infected with C-P5 at an MOI of 0.006 and incubated for 7 days to generate a new
stock (C-P6) (55). The flasks were freeze-thawed three times to generate whole-cell/supernatant lysate.
Next, C-P6 was inoculated into T175 flasks containing confluent Caco-2 cells at an MOI of 0.01 and
incubated for 5 days. Flasks were freeze-thawed three times, and the lysate (C-P7) was quantified by a
TCID50 assay (3.16 107 TCID50 units/ml) and used in all subsequent experiments (55).
A stock of HAstV4 was also generated by passage in Caco-2 cells. A 100-l aliquot of stock virus was
activated by incubation with 100 g/ml of trypsin (Gibco) for 30 min. The trypsin-treated virus was then
inoculated into Caco-2 cells, and the cells were maintained in SFM supplemented with 3.3 g/ml of
trypsin for 7 days. The cells were freeze-thawed three times, and the viral titer was determined by a
TCID50 assay (2.8 105 TCID50 units/ml). This stock was used in all HAstV4 experiments.
C-P7 VA1 was passaged twice in primary astrocytes grown in a 6-well plate, starting with an initial
MOI of 0.1. After 5 days, the cells were freeze-thawed three times (A-P1 stock), and 200 l of cell lysate
was added to uninfected astrocytes. The cells were incubated for 5 days and freeze-thawed three times
(A-P2 stock), and RNA was extracted from the cell lysate of both passages.
Sequencing the VA1 genome. TRIzol reagent (Thermo Fisher) was added to 100 l of the C-P7 stock
or 200 l of the A-P2 stock, and RNA was extracted using Direct-zol miniprep columns (Zymo Research).
Reverse transcription was performed using oligo(dT) with Superscript IV (Thermo Fisher) at a RT
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temperature of 60°C for 10 min. The cDNA was then used in PCRs with PfuUltra II Fusion HS DNA
polymerase (Agilent) and with previously published primer combinations for sequencing of the VA1
genome (31). For sequencing of the VA1 isolate from A-P2, two changes were made to the PCR protocol.
First, the number of PCR cycles was increased to 40 for all primer combinations of the genome. Second,
the annealing temperature for fragments 1 and 4 was increased to 58°C. The genome from each stock
was sequenced in three independent experiments, and genetic variants were identified if they were
present in at least two of the three experiments.
Single and multistep growth curves. For multistep growth curve analyses, VA1 or HAstV4 was
inoculated into the cell lines at an MOI of 0.01 with three replicates for each time point. For VEEV, an MOI
of 0.1 was used. Cell and supernatant fractions were collected at 1, 12, 24, 36, 48, and 96 h after
inoculation. In single-step growth curves for VA1, cells were infected at an MOI of 3 with three replicates
at each time point. Both cell and supernatant fractions were collected at 1, 6, 12, 24, 36, and 48 h after
inoculation. The supernatant was collected for both growth curves and frozen at 80°C. The cellular
fraction was collected by adding TRIzol reagent to the wells, transferring the mixture to microcentrifuge
tubes, and freezing at 80°C.
RNA extraction and qRT-PCR. Aliquots of the supernatant fraction were lysed in TRIzol. RNA from
the cellular or supernatant fractions was extracted by the use of Direct-zol 96-well plates (Zymo
Research). VA1 gRNA was quantified using a previously published TaqMan-based qRT-PCR assay (31, 55).
To quantify HAstV4 RNA, we adapted a previously published qRT-PCR assay (16, 57). The HAstV primers
and probe were as follows: forward primer, 5=-TCAACGTGTCCGTAAMATTGTCA-3=; HAstV reverse primer,
5=-TGCWGGTTTTGGTCCTGTGA-3=; TaqMan probe, 5=-(56–6-carboxyfluorescein [FAM])CAACTCAGG/ZEN/
AAACARG/3IABkFQ/-3= (Integrated DNA Technologies [IDT]). For quantification of VA1 sgRNA, we devel-
oped a qRT-PCR assay targeting a region within ORF2 common to both the genomic and sub-
genomic strands (sg/gRNA qRT-PCR assay) using the following primers and probe: forward primer AJ135
(5=-GTGTTGGACCAAGATCAGATG-3=), reverse primer AJ137 (5=-CAGAACTAGAGGAGTCTGAATCC-3=), and
probe AJ136 (5=-56-FAM/TCAAATTCA/ZEN/GCATCGCTACAGATTGACC/3IABkFQ/-3=) (IDT). VEEV RNA was
quantified by the use of a previously published qRT-PCR protocol and normalized to the calculated PFU
(58).
To generate positive-control RNA, we used two plasmids as the templates for in vitro transcription
(IVT). Plasmid DW737 contains a 370-bp sequence of the HAstV4 genome, and plasmid DW738 contains
a 490-bp region containing the VA1 region for the sg/gRNA qRT-PCR. Both plasmids were linearized with
Pst-I (New England Biolabs) and subjected to RNA transcription using a MEGAscript T7 kit (Thermo
Fisher). The RNA was purified using an RNeasy kit (Qiagen) and quantified using a NanoDrop 1000
spectrophotometer (Thermo Scientific). qRT-PCR was performed using TaqMan Fast Virus 1-Step master
mix (Applied Biosystems) and a ViiA 7 real-time PCR system (Applied Biosystems), with an annealing
temperature of 55°C. Three replicates of 10-fold serial dilutions of the IVT RNA were used to generate a
standard curve. The cycle threshold (CT) and RNA copy number data were plotted, and a linear regression
model was determined from the values using Prism version 8.0.2 (GraphPad) to quantify viral RNA (see
Fig. S1 in the supplemental material).
The copy number for VA1 or HAstV4 RNA was calculated for each time point for the single-step and
multistep growth curves from two separate experiments. Data from samples with undetectable levels
were transformed to the CT limit of detection for each assay. These values were normalized to the 1-h
time point, and the geometric mean and geometric standard deviation were calculated for each time
point and graphed in Prism.
For calculation of VA1 sgRNA, we subtracted the value corresponding to the result of the gRNA assay
from that corresponding to the sg/gRNA assay result. This value was normalized to the 1-h time point
with geometric means and geometric standard deviations calculated and graphed in Prism. We com-
pared logarithmically transformed data from primary astrocytes and SK-N-SH, SW-1088, and U87 MG cells
at time points 24, 36, and 48 h using a two-way ANOVA with a post hoc analysis of multiple comparisons
completed using Tukey’s multiple-comparison test in Prism. Adjusted P values of 0.05 were considered
significant.
For quantification of host mRNA, extracted RNA from mock-infected cells and infected cells (MOI
of 3) at 24 and 48 h postinoculation was treated with DNase I (Thermo Fisher) for 15 min at room
temperature. EDTA was then added, and the mixture was incubated at 65°C for 10 min. TaqMan Fast
Virus 1-Step master mix was then added to the DNase-treated samples, and the reaction mixture was
analyzed by qRT-PCR using commercial assays for the following: RPLP0 (IDT; catalog no.
Hs.PT.39a.22214824), MCP-1 (IDT; catalog no. Hs.PT.58.45467977), and CXCL10 (IDT; catalog no.
Hs.PT.58.3790956.g). The annealing temperature for all assays was 55°C. Relative quantities of RNA were
calculated using the 2-ΔΔCT method, with RPLP0 as the housekeeping gene, and graphed via Prism.
Undetectable samples were normalized to a CT value of 40. The ΔCT value for each gene was also
calculated for mock-infected or infected cells at each time point and compared via multiple t tests with
a correction for multiple comparisons by the Holm-Sidak method in Prism. Adjusted P values of 0.05
were considered significant.
Quantification of infectious particles by TCID50 assays. We used a previously published qRT-PCR-
based TCID50 assay to quantify VA1 or HAstV4 infectious particles (31, 55). All viral infections were
performed in triplicate with completion of two independent experiments. Whole-cell lysates were
collected 1, 48, or 96 h postinoculation and freeze-thawed three times. Lysates from HAstV4-infected cells
were incubated with 100 g/ml of trypsin for 30 min, while the VA1 cell lysate was not pretreated with
trypsin. Caco-2 cells grown in 96-well plates were then infected using 10-fold dilutions of each lysate in
quadruplicate, starting with 10 l of the cell lysate per well. After the infection step, Caco-2 cells
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inoculated with HAstV4 were maintained in SFM supplemented with 3.3 g/ml of trypsin, while VA1-
infected cells were maintained in FBS-containing media. Cells were incubated for 72 h and cell fractions
collected in TRIzol for RNA extraction. qRT-PCR was performed on the RNA extracts using the HAstV4 or
VA1 assays. The Spearman-Karber method was used to calculate the TCID50 value for each sample as
wells were deemed infected if the CT value from the qRT-PCR assay was 30 (31, 55, 59, 60). The
geometric mean for each viral titer at each time point was calculated, and the data from the different
time points were compared using a Kruskal-Wallis test with post hoc testing by Dunn’s multiple-
comparison test; P values of 0.05 were considered significant.
Production of rabbit polyclonal anti-VA1 capsid antibody. The VA1 capsid sequence was ana-
lyzed using OptimumAntigen (GenScript) to identify antigenic regions, and an optimal peptide sequence
was selected from amino acid positions 532 to 545 (YP_003090288.1) for antibody production. A cysteine
residue (CNSEEWHTNAEQPHQ) was added to the N terminus to facilitate conjugation. The peptide was
commercially produced and inoculated into rabbits by the vendor (GenScript). Preimmune sera and
affinity-purified antibody (WAB111; 1.32 mg/ml) were collected from sera 35 days postinoculation.
Immunofluorescence assay for detection of VA1 capsid in cell culture. Glass coverslips were
coated with sterile 0.1% gelatin or 2 g/cm2 of poly-L-lysine (primary astrocytes) for at least 1 h in a
24-well plate. The mixture was removed, and cells were added to the wells. After adhering to the plate
for 24 to 48 h, cells were either subjected to mock infection or infected with VA1 at an MOI of 3. At 48 h
postinoculation, cells were washed once with phosphate-buffered saline (PBS) and fixed with 4%
paraformaldehyde for 10 min. The cells were washed 3 times with PBS and then permeabilized with PBS
with 0.1% Triton X-100 for 10 min. The cells were washed once with PBS for 5 min and then blocked
overnight with 10% horse serum–PBS at 4°C. After blocking, a 1:1,000 dilution of WAB111 or preimmune
sera in PBS with 10% bovine serum albumin and 0.05% Tween 20 (Ab buffer) was added to the coverslips.
After a 1 h incubation at 4°C, the coverslips were washed for 5 min with PBS–0.05% Tween 20 (PBS-T)
three times. A 1:1,000 dilution of donkey anti-rabbit antibodies conjugated with Alexa Fluor 488 (Thermo
Fisher) was diluted in Ab buffer and incubated with the coverslips at room temperature for 1 h. The cells
were washed five times with PBS-T and stained with 600 nM DAPI (4=,6-diamidino-2-phenylindole;
Thermo Fisher) for 5 min, and a final wash with PBS-T was performed. Coverslips were mounted using
ProLong Gold Antifade mounting media (Thermo Fisher). The coverslips were then visualized using a
Zeiss LSM880 confocal laser scanning microscope at 63 magnification. Images were cropped and
labeled using the Zen 2.3 lite application (Carl Zeiss Microscopy). For quantification of the frequency of
infected cells, a 1.1-mm-by-1.1-mm region from each coverslip was imaged, with a total of two coverslips
imaged for each cell type. The number of VA1-positive cells was counted and divided by the total
number of cells in the field as represented by the number of DAPI-positive nuclei determined by the use
of Fiji software.
Cytokine expression of infected cells. Supernatant fractions of two independent infection exper-
iments (MOI of 3; 3 replicates each) were analyzed by multiplex ELISA for IFN-2, IFN-, TNF-, IL-1,
IL-1, MCP-1, CXCL10, IL-6, IL-8, and VEGF (Milliplex; MilliporeSigma). Duplicate 25-l volumes of each
sample were added to a 96-well plate and diluted in assay buffer with premixed beads targeting each
individual cytokine. Samples were incubated overnight at 4°C on a plate shaker. The plate was then
washed twice, and detection antibodies were added. The plate was incubated for 1 h at room
temperature, and then streptavidin and phycoerythrin were added to each well. The plate was incubated
for 30 min at room temperature and then washed twice. The plate was then analyzed on a Bio-Plex 200
system (Bio Rad). Geometric mean concentrations were calculated for each cytokine, and differences
between mock-infected and infected samples were determined by multiple t tests with correction for
multiple comparisons by the use of the Holm-Sidak method in Prism. Adjusted P values of 0.05 were
considered significant.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.01455-19.
FIG S1, EPS file, 0.02 MB.
FIG S2, EPS file, 0.1 MB.
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